Title of article
Pyrazinamide monoresistance in clinical isolates
Author/Authors
KALIR, Nezaket State Hospital - Department of Medical Microbiology, Turkey , ÖZKÜTÜK, Ayşe Aydan Dokuz Eylül University - Faculty of Medicine - Department of Medical Microbiology, Turkey , ESEN, Nuran Dokuz Eylül University - Faculty of Medicine - Department of Medical Microbiology, Turkey , ÖZKÜTÜK, Nuri Celal Bayar University - Faculty of Medicine - Department of Medical Microbiology, TURKEY
From page
163
To page
167
Abstract
Aim: To determine pyrazinamide (PZA) monoresistance in clinical isolates of Mycobacterium tuberculosis complex (MTBC) isolated in hospitals in and around İzmir.Materials and methods: The study was performed between 2004 and 2009 with 150 streptomycin, isoniazid, rifampicin, and ethambutol susceptible MTBC clinical strains isolated in the university hospitals of İzmir and Manisa. The PZA susceptibility of the isolates was determined by the BACTEC 460 TB test.Results: The results indicated that resistance to PZA was present in 5 (3.3%) of the 150 MTBC isolates susceptible to all primary drugs except PZA.Conclusion: It is not essential to perform PZA susceptibility tests routinely along with other primary drugs due to the low PZA monoresistance level in our region.
Keywords
Mycobacterium tuberculosis , antituberculosis susceptibility test , pyrazinamide resistance , BACTEC 460TB
Journal title
Turkish Journal of Medical Sciences (TJMS)
Journal title
Turkish Journal of Medical Sciences (TJMS)
Record number
2529894
Link To Document